Compounds > azathioprine

azathioprine and hydroxychloroquine

azathioprine has been researched along with hydroxychloroquine in 137 studies

Research

Studies (137)

TimeframeStudies, this research(%)All Research%
pre-199019 (13.87)18.7374
1990's20 (14.60)18.2507
2000's27 (19.71)29.6817
2010's45 (32.85)24.3611
2020's26 (18.98)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Evens, RP1
Clarke, AK; Currey, HL; Vernon-Roberts, B1
Callahan, LF; Marcum, SB; Pincus, T1
Hymes, SR; Jordon, RE1
Bloch, DA; Fries, JF; Singh, G; Spitz, P; Williams, CA; Zatarain, E1
Clough, JD; Wilke, WS1
Hanno, PM; Wein, AJ1
Ehrenfeld, M; Kaplinsky, N; Langevitz, P; Pras, M1
Clegg, DO; Ward, JR1
Dugowson, CE; Gilliland, BC1
Miescher, PA1
Franks, A; Werth, V1
Kovarsky, J1
Carrera, GF; Csuka, M; McCarty, DJ1
Candy, JC; Cowan, R; Mallinson, CN; Prior, A1
Dubernard, J; Murray, JE; Retik, A1
Bickers, DR; Callen, JP; Hanno, R; Hawkins, C; Voorhees, JJ; Woo, TY1
Bernhard, JD; Gange, RW; Haynes, HA1
Carrera, GF; McCarty, DJ1
Bunch, TW; O'Duffy, JD1
Paulus, HE1
Ehrlich, GE1
Adams, LB; King, LE; Olsen, NJ; Park, JH1
Meenan, RF; Prashker, MJ1
van 't Hof, M; van de Putte, LB; van der Heijde, DM; van Riel, PL1
Callahan, LF; Pincus, T1
Fagundus, DM; Leroy, EC1
McCarty, DJ1
Mehregan, DR; Su, WP1
Bloch, DA; Fries, JF; Ramey, D; Williams, CA1
Spencer-Green, G1
Alves, J; Buchanan, NM; Hughes, GR; Khamashta, MA; Lima, F; Ruiz-Irastorza, G; Simpson, J1
Haagsma, CJ; van Riel, PL1
Wollenhaupt, J; Zeidler, H1
Choquette, D; Cividino, A; Danoff, D; Esdaile, JM; Joseph, L; Osterland, CK; Senécal, JL; Smith, CD; Tsakonas, E; Yeadon, C1
McCune, WJ; Singer, NG1
Camisa, C; Shteyngarts, AR; Warner, MR1
Koler, RA; Montemarano, A1
Pisetsky, DS; St Clair, EW1
Baranauskaite, A; Misiūniene, N1
Arlet, P; Astudillo, L; Carreiro, M; Dahan, S; Ollier, S; Sailler, L1
Petri, M1
Harten, P1
Choksi, MT; Shahnaz, S; Tan, IJ1
Airò, P; Biggioggero, M; Borghi, O; Cimaz, R; Meregalli, E; Meroni, PL; Motta, M; Tincani, A1
Emery, P; Suarez-Almazor, M1
Issa, SN; Ruderman, EM1
Constantin, E; Dancey, P; Duffy, CM; Scuccimarri, R1
Chang, DM; Chen, CH; Chen, HC; Gao, HW; Huang, GS; Kuo, SY; Lai, JH1
Aries, PM; Reinhold-Keller, E1
Bansal, A; Singh, S1
Benne, CA; Bijl, M; De Vries, JJ; Holvast, A; Horst, G; Huckriede, A; Kallenberg, CG; Wilschut, J1
Barber, CE; Geldenhuys, L; Hanly, JG1
Kessel, A; Paran, D; Rosner, I; Rozenbaum, M; Shoenfeld, Y; Toubi, E1
Lesiak, A; McCauliffe, DP; Salamon, M; Sysa-Jedrzejowska, A; Wozniacka, A1
Bank, I; Ben-Horin, S; Langevitz, P; Levi, Y; Livneh, A; Schiby, G; Tweezer-Zaks, N1
Matsuda, T; Ohtsubo, H1
Berndt, S; Foerster, J; Rüther, K; Schroeter, J1
Chirico, G; Ciardelli, L; Gasparoni, A; Lojacono, A; Marconi, M; Motta, M; Tincani, A1
Beyhan, S; Can, B; Kavala, M; Kocaturk, E; Kuru, I; Sudogan, S; Zindanci, I1
Brasington, R1
Baig, MS; Humail, SM; Riaz, A; Suhail, S1
Lateef, A; Lau, TC; Tan, KB1
Ablin, JN; Aloush, V; Boguslavski, V; Caspi, D; Elkayam, O; George, J; Levartovski, D; Paran, D1
Neves, FS; Nobre, LF; Pereira, IA; Rodrigues, K; Stoeterau, KB; Werner Castro, GR; Zimmermann, AF1
Beers, MF; Griese, M; Hartl, D; Hector, A; Kern, S; Liebisch, G; Mulugeta, S; Schmitz, G; Sparr, C; Thurm, T; Woischnik, M1
Khamashta, MA; Ruiz-Irastorza, G1
Balbir-Gurman, A; Bergman, R; Braun-Moscovici, Y; Egozi, D; Markovits, D; Melamed, Y; Ramon, Y; Rozin, AP; Schapira, D; Toledano, K; Ullman, Y1
Boorugu, HK; Chrispal, A; Thomas, EM; Vasuki, Z1
Albayram, S; Erer, B; Hasiloglu, ZI; Islak, C; Selcuk, H; Tasmali, K1
Altiparmak, E; Efe, C; Karaaslan, Y; Muratori, P; Ozaslan, E; Ozbalkan, Z; Purnak, T; Wahlin, S1
Boomershine, CS; Cole, MB; Dash, A; Eyler, A; Richmond, BW1
Chen, DY; Chen, YM; Lai, PJ; Wey, SJ1
Amoura, Z; Barete, S; Benveniste, O; Bourgeois, P; Cacoub, P; Dubourg, O; Francès, C; Gatfossé, M; Lebeaux, D; Maisonobe, T; Piette, JC; Renoux, J; Sène, D; Wechsler, B1
Bhangle, S; Noaiseh, G; Vivino, F1
Griese, M; Hartl, D; Hector, A; Kaltenborn, E; Kern, S; Liebisch, G; Schmitz, G; Sparr, C; Thurm, T; Woischnik, M; Zarbock, R1
Miller, AV; Ranatunga, SK1
Amoura, Z; Aringer, M; Bajema, I; Berden, JH; Bertsias, GK; Boletis, J; Boumpas, DT; Cervera, R; Doria, A; Dörner, T; Ferrario, F; Floege, J; Gordon, C; Haubitz, M; Houssiau, FA; Ioannidis, JP; Isenberg, DA; Jayne, D; Kallenberg, CG; Lightstone, L; Marks, SD; Martini, A; Moroni, G; Neumann, I; Praga, M; Schneider, M; Starra, A; Tektonidou, M; Tesar, V; van Vollenhoven, RF; Vasconcelos, C; Zakharova, H1
Foroughipour, M; Nikbin, Z; Pezeshki Rad, M; Sahebari, M; Shoeibi, A1
Bozkirli, DE; Bozkirli, E; Kozanoglu, I; Yucel, E1
Amoiridis, G; Bertsias, G; Boumpas, DT; Fanouriakis, A; Mastorodemos, V; Pamfil, C; Papadaki, E; Plaitakis, A; Sidiropoulos, P1
Clowse, ME; Peart, E1
Boura, P; Gkougkourelas, I; Sarantopoulos, A; Tselios, K1
Batat, E; Bitterman, H; Cohen, AD; Cohen, S; Comanesther, D; Feldhamer, I; Greenberg-Dotan, S; Shalom, G; Zisman, D1
Amlani, B; Goldberg, JW; Sehgal, R; Yachoui, R1
Croyle, L; Morand, EF1
Freitas, A; Guedes, M; Marinho, A; Senra, V1
Chen, CJ; Cheng, TT; Lin, JC; Lin, KM1
Bermas, BL; Costenbader, KH; Fine, A; Guan, H; Massarotti, E; Tedeschi, SK1
Cuadrado, MJ; Hunt, BJ; Khamashta, MA; Lliso, G; Sciascia, S; Talavera-Garcia, E1
Bakardzhiev, I; Chokoeva, AA; Krasnaliev, I; Lotti, T; Tana, C; Tchernev, G; Wollina, U1
Danaei, G; Desai, RJ; Kim, SC; Liao, KP; Schneeweiss, S; Solomon, DH1
Elfving, P; Kaipiainen-Seppänen, O; Kautiainen, H; Pohjolainen, T; Puolakka, K; Virta, LJ1
Clowse, ME; Noviani, M; Wasserman, S1
Chen, GS; Hu, SC; Lin, CL; Lin, YC; Wang, TN; Yen, FL1
Awdishu, L; Joy, MS1
Adelowo, OO; Akintayo, RO; Animashaun, BA; Olaosebikan, BH1
Karokis, D; Liossis, SC; Staveri, C1
Apostolopoulos, D; Morand, EF1
Gladman, DD; Pakchotanon, R; Polachek, A; Su, J; Tselios, K; Urowitz, MB; Yap, KS1
Davis, LS; Reimold, AM1
Campanilho-Marques, R; Deakin, CT; Moraitis, E; Pilkington, CA; Pullenayegum, E; Simou, S; Wedderburn, LR1
Benedetto, C; Biancone, L; Colla, L; Diena, D; Manzione, AM; Marozio, L; Rossetti, M1
Berman, JS; Govender, P; Raghu, G1
Yates, M1
De, H; Ganguly, N; Giri, PP; Mandal, A; Pal, P1
Chehab, G; Fehm, T; Fischer-Betz, R; Germeyer, A; Kreuzer, V; Krüssel, J; Liebenthron, J; Schneider, M; Suerdieck, MB1
Asseri, AA; Daines, CL; Zeng, Y1
Amiri, N; Baldwin, C; De Vera, MA; Rebić, N; Sayre, EC; Zusman, EZ1
Benvenuti, F; Doria, A; Gatto, M; Iaccarino, L; Larosa, M; Montesso, G; Saccon, F; Zen, M1
Cash, K; Greenberg, SA; Hissaria, P; Koszyca, B; Limaye, VS; Patel, S; Smith, C1
Anders, HJ; Aringer, M; Bajema, I; Bertsias, G; Boletis, J; Boumpas, DT; Cheema, K; Fanouriakis, A; Frangou, E; Hollis, J; Houssiau, FA; Jayne, D; Karras, A; Kostopoulou, M; Marchiori, F; Marks, SD; Moroni, G; Mosca, M; Parodis, I; Praga, M; Schneider, M; Smolen, JS; Teng, YKO; Tesar, V; Trachana, M; van Leew, B; van Vollenhoven, RF; Voskuyl, AE1
Biglia, A; Bozzalla Cassione, E; Cavagna, L; Codullo, V; Montecucco, C; Zanframundo, G1
Bertsias, G; Boumpas, DT; Fanouriakis, A; Tziolos, N1
Hammad, I; Porter, TF1
Charan, N; Kam, JK; Leong, RW; Loh, ZW; Thong, BY1
Abou Chahla, W; Aladjidi, N; Armari-Alla, C; Barlogis, V; Bayart, S; Bertrand, Y; Cheikh, N; Ducassou, S; Fernandes, H; Guitton, C; Kherfellah, D; Laghouati, S; Leblanc, T; Leverger, G; Pasquet, M; Pellier, I; Savel, H; Thiébaut, R; Thomas, C; Vassal, G1
Isenberg, D; Lorenzo-Vizcaya, A1
Birring, S; Brex, P; Galloway, J; Larkin, G; Murgatroyd, F; Paolino, A; Patel, A; Sado, D; Walsh, S1
Bennett, C; Chen, S; Hannon, CW; Lima, HC; McCourt, C1
Al-Obaidi, M; Ciurtin, C; Doolan, G; Faizal, NM; Foley, C; Jury, EC; Lieberman, SM; Price, E; Ramanan, AV1
Arkema, EV; Gunnarsson, I; Rossides, M; Simard, JF; Svenungsson, E1
Appelt, LM; Beissert, S; Günther, C; Lander, F1
Bertsias, G; Boki, K; Boumpas, DT; Dania, V; Dimopoulou, D; Emmanouilidou, E; Fanouriakis, A; Kallitsakis, I; Nikolopoulos, D; Ntali, S; Pantazi, L; Papagoras, C; Sidiropoulos, PI1
Chudal, D; Pandey, BR; Paudel, V; Pradhan, MB; Thakur, R1
Ahmed, A; Carol, HA; Ochfeld, EN1
Filippa, MG; Panopoulos, S; Sfikakis, PP; Spanos, E; Spanos, G; Tektonidou, MG; Yavropoulou, MP1
Akil, M; Bruce, IN; Edwards, CJ; Gayed, M; Giles, I; Gordon, C; Khamashta, MA; Leone, F; McHugh, N; Reynolds, JA; Teh, LS; Toescu, V1
Kotar, AM; Smedslund, G; Uhlig, T1
Balevic, SJ; Burckart, GJ; Chen, J; Glaser, R; Gonzalez, D; Green, D; Hornik, CP; McMahon, A; Niu, J; Schanberg, LE1
Duruöz, MT; Esen, İ; Gezer, HH; Karabulut, Y; Öz, N1
Antoni, C; Bergner, R; Ebert, MP; Galle, PR; Hetjens, S; Qian, Y; Schlevogt, B; Schmidt, HJ; Sollors, J; Teufel, A; Weis, CA; Woerns, MA1
Barrett, R; Culliford, D; Edwards, CJ; Fraser, S; Lin, SX1
Lomanto Silva, R; Magnani, JW; Sattui, SE; Swabe, GM1

Reviews

33 review(s) available for azathioprine and hydroxychloroquine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Therapy for rheumatoid arthritis: combinations of disease-modifying drugs and new paradigms of treatment.
    Seminars in arthritis and rheumatism, 1991, Volume: 21, Issue:2 Suppl 1

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Penicillamine

1991
Medical treatment of interstitial cystitis (other than Rimso-50/Elmiron).
    Urology, 1987, Volume: 29, Issue:4 Suppl

    Topics: Administration, Intravesical; Administration, Oral; Amitriptyline; Azathioprine; Benzenesulfonates; Benzydamine; Chloroquine; Cystitis; Heparin; Histamine H1 Antagonists; Humans; Hydroxychloroquine; Pentosan Sulfuric Polyester; Prednisolone; Silver Nitrate

1987
Management of rheumatoid arthritis.
    Disease-a-month : DM, 1986, Volume: 32, Issue:1

    Topics: Anti-Inflammatory Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Cyclophosphamide; Drug Therapy, Combination; Felty Syndrome; Gold; Humans; Hydroxychloroquine; Immunosuppressive Agents; Leukapheresis; Lung Diseases; Lymphoid Tissue; Methotrexate; Penicillamine; Plasmapheresis; Radiotherapy; Rheumatic Diseases; Salicylates; Sjogren's Syndrome; Spinal Diseases; Vasculitis

1986
Treatment of systemic lupus erythematosus.
    Springer seminars in immunopathology, 1986, Volume: 9, Issue:2-3

    Topics: Azathioprine; Cyclophosphamide; Cyclosporins; Drug Therapy, Combination; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methylprednisolone; Plasmapheresis; Steroids

1986
Disease-modifying drugs for progressive rheumatoid arthritis.
    Mayo Clinic proceedings, 1980, Volume: 55, Issue:3

    Topics: Arthritis, Rheumatoid; Aurothioglucose; Azathioprine; Chloroquine; Cyclophosphamide; Gold; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Penicillamine; Retinal Diseases

1980
Drug treatment of arthritis. Update on conventional and less conventional methods.
    Postgraduate medicine, 1993, May-15, Volume: 93, Issue:7

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aurothioglucose; Azathioprine; Glucosamine; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Methotrexate; Osteoarthritis; Ribose

1993
Combination of second-line antirheumatic drugs.
    Annals of medicine, 1997, Volume: 29, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Juvenile; Azathioprine; Child; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine; Treatment Outcome

1997
[Combined administration of long-acting antirheumatic drugs in the treatment of chronic polyarthritis].
    Deutsche medizinische Wochenschrift (1946), 1997, Oct-02, Volume: 122, Issue:40

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Clinical Trials as Topic; Cyclosporins; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Humans; Hydroxychloroquine; Immunosuppressive Agents; Methotrexate; Organogold Compounds; Penicillamine; Prospective Studies; Randomized Controlled Trials as Topic; Sulfasalazine

1997
Update on immunosuppressive therapy.
    Current opinion in rheumatology, 1998, Volume: 10, Issue:3

    Topics: Adult; Arthritis, Juvenile; Azathioprine; Behcet Syndrome; Child; Cladribine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Hydroxychloroquine; Immunosuppressive Agents; Liver; Lung; Lung Injury; Lupus Erythematosus, Systemic; Methotrexate; Pemphigoid, Benign Mucous Membrane; Retina; Tacrolimus; Thalidomide

1998
Lupus erythematosus associated with erythema multiforme: does Rowell's syndrome exist?
    Journal of the American Academy of Dermatology, 1999, Volume: 40, Issue:5 Pt 1

    Topics: Adult; Azathioprine; Cathartics; Dermatologic Agents; Diagnosis, Differential; Erythema Multiforme; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Phenolphthalein; Prednisone; Recurrence; Syndrome

1999
Dermatomyositis.
    American family physician, 2001, Nov-01, Volume: 64, Issue:9

    Topics: Adult; Azathioprine; Child; Dermatologic Agents; Dermatomyositis; Diagnosis, Differential; Female; Humans; Hydroxychloroquine; Methotrexate; Polymyositis; Prednisone; Prognosis

2001
Progress in the treatment of rheumatoid arthritis.
    JAMA, 2001, Dec-12, Volume: 286, Issue:22

    Topics: Analgesics; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine

2001
Immunosuppressive drug use in pregnancy.
    Autoimmunity, 2003, Volume: 36, Issue:1

    Topics: Adrenal Cortex Hormones; Azathioprine; Breast Feeding; Cyclophosphamide; Cyclosporine; Female; Fetal Diseases; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Maternal-Fetal Exchange; Mycophenolic Acid; Pregnancy; Pregnancy Complications

2003
Rheumatoid arthritis.
    Clinical evidence, 2003, Issue:9

    Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine

2003
Damage control in rheumatoid arthritis. Hard-hitting, early treatment is crucial to curbing joint destruction.
    Postgraduate medicine, 2004, Volume: 116, Issue:5

    Topics: Arthritis, Rheumatoid; Azathioprine; Disease Progression; Humans; Hydroxychloroquine; Immunologic Factors; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine

2004
Systemic lupus erythematosus with simultaneous onset of Kikuchi-Fujimoto's disease complicated with antiphospholipid antibody syndrome: a case report and review of the literature.
    Rheumatology international, 2005, Volume: 25, Issue:4

    Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Anticoagulants; Antiphospholipid Syndrome; Antirheumatic Agents; Aspirin; Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heparin; Histiocytic Necrotizing Lymphadenitis; Humans; Hydroxychloroquine; Injections, Intravenous; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Treatment Outcome; Venous Thrombosis

2005
[Effective combination therapy of TNF antagonists with DMARDs].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Volume: 65, Issue:7

    Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cysteine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Receptors, Tumor Necrosis Factor; Sulfasalazine; Tumor Necrosis Factor-alpha

2007
An extremely severe case of cutaneous calcinosis complicating adult dermatomyositis.
    Clinical and experimental dermatology, 2009, Volume: 34, Issue:1

    Topics: Adult; Antirheumatic Agents; Azathioprine; Calcinosis; Dermatomyositis; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Prednisolone; Skin Diseases

2009
Lupus and pregnancy: integrating clues from the bench and bedside.
    European journal of clinical investigation, 2011, Volume: 41, Issue:6

    Topics: Abortion, Spontaneous; Antibodies, Antiphospholipid; Anticoagulants; Aspirin; Azathioprine; Counseling; Enzyme Inhibitors; Female; Fetal Death; Heparin; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Postpartum Period; Practice Guidelines as Topic; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Prenatal Care; Risk Factors

2011
Immunotherapies in rheumatologic disorders.
    The Medical clinics of North America, 2012, Volume: 96, Issue:3

    Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Certolizumab Pegol; Colchicine; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Mycophenolic Acid; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatic Diseases; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors

2012
Systemic lupus erythematosus and pregnancy outcomes: an update and review of the literature.
    Current opinion in rheumatology, 2014, Volume: 26, Issue:2

    Topics: Antibodies, Monoclonal, Humanized; Azathioprine; Cohort Studies; Female; Heart Block; Humans; Hydroxychloroquine; Infant, Newborn; Lupus Erythematosus, Systemic; Lupus Nephritis; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Retrospective Studies

2014
Optimizing the use of existing therapies in lupus.
    International journal of rheumatic diseases, 2015, Volume: 18, Issue:2

    Topics: Antimetabolites, Antineoplastic; Azathioprine; Cohort Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Long-Term Care; Lupus Erythematosus, Systemic; Male; Mycophenolic Acid; Prognosis; Prospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; Treatment Outcome

2015
Role of Pharmacogenomics in Kidney Disease and Injury.
    Advances in chronic kidney disease, 2016, Volume: 23, Issue:2

    Topics: Acute Kidney Injury; Azathioprine; Calcineurin Inhibitors; Cisplatin; Cyclophosphamide; Cytochrome P-450 Enzyme System; Enzymes; Glomerulonephritis; Humans; Hydroxychloroquine; Membrane Transport Proteins; Mycophenolic Acid; Pharmacogenetics; Polymorphism, Genetic; Rituximab; Tacrolimus; Tenofovir

2016
It hasn't gone away: the problem of glucocorticoid use in lupus remains.
    Rheumatology (Oxford, England), 2017, 04-01, Volume: 56, Issue:suppl_1

    Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Azathioprine; Cardiovascular Diseases; Cataract; Cushing Syndrome; Diabetes Mellitus; Disease Progression; Evidence-Based Medicine; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mycophenolic Acid; Osteonecrosis; Osteoporotic Fractures

2017
Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.
    Rheumatology (Oxford, England), 2017, 04-01, Volume: 56, Issue:suppl_1

    Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Drug Discovery; Glucocorticoids; Humans; Hydroxychloroquine; Immunologic Factors; Immunosuppressive Agents; Interleukin-2; Lupus Erythematosus, Systemic; Methotrexate; Molecular Targeted Therapy; Mycophenolic Acid; Recombinant Fusion Proteins; Rituximab; Ustekinumab; Vitamin D

2017
Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era.
    Journal of nephrology, 2018, Volume: 31, Issue:3

    Topics: Azathioprine; Biological Products; Calcineurin Inhibitors; Cyclophosphamide; Directive Counseling; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Mycophenolic Acid; Pregnancy; Pregnancy Complications; TOR Serine-Threonine Kinases

2018
Treatment of Sarcoidosis.
    American journal of respiratory and critical care medicine, 2018, 03-15, Volume: 197, Issue:6

    Topics: Adrenal Cortex Hormones; Azathioprine; Enzyme Inhibitors; Humans; Hydroxychloroquine; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Sarcoidosis

2018
Update οn the diagnosis and management of systemic lupus erythematosus.
    Annals of the rheumatic diseases, 2021, Volume: 80, Issue:1

    Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Humanized; Autoantibodies; Azathioprine; Calcineurin Inhibitors; Cardiovascular Diseases; Cyclophosphamide; Disease Management; Female; Glucocorticoids; Heart Valve Diseases; Humans; Hydroxychloroquine; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Lupus Vasculitis, Central Nervous System; Macrophage Activation Syndrome; Methotrexate; Mycophenolic Acid; Myocarditis; Outcome Assessment, Health Care; Pericarditis; Phenotype; Pregnancy; Pregnancy Complications; Prognosis; Purpura, Thrombocytopenic, Idiopathic; Quality of Life; Recurrence; Rituximab; Severity of Illness Index; Survival Rate; Uterine Cervical Neoplasms

2021
An Update on Biologic Agents During Pregnancy.
    Clinics in perinatology, 2020, Volume: 47, Issue:4

    Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Autoimmune Diseases; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Female; Fetal Growth Retardation; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Premature Birth; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors

2020
Interventions for cutaneous disease in systemic lupus erythematosus.
    The Cochrane database of systematic reviews, 2021, 03-09, Volume: 3

    Topics: Age of Onset; Azathioprine; Bias; Biological Factors; Chloroquine; Cosmetic Techniques; Cyclosporine; Dermatologic Agents; Exanthema; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Male; Medicine, Chinese Traditional; Methotrexate; Placebos; Quality of Life; Randomized Controlled Trials as Topic; Skin Diseases; Symptom Flare Up

2021
Treatment strategies for Sjögren's syndrome with childhood onset: a systematic review of the literature.
    Rheumatology (Oxford, England), 2022, 03-02, Volume: 61, Issue:3

    Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Hydroxychloroquine; Methotrexate; Rituximab; Sjogren's Syndrome

2022
Sarcoidosis with musculoskeletal manifestations: systematic review of non-pharmacological and pharmacological treatments.
    Rheumatology international, 2022, Volume: 42, Issue:12

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Humans; Hydroxychloroquine; Methotrexate; Sarcoidosis; Tumor Necrosis Factor Inhibitors

2022

Trials

7 trial(s) available for azathioprine and hydroxychloroquine

ArticleYear
Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
    The Journal of rheumatology, 1991, Volume: 18, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Female; Follow-Up Studies; Gold; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Penicillamine

1991
Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine.
    JAMA, 1982, Oct-08, Volume: 248, Issue:14

    Topics: Arthritis, Rheumatoid; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Hand; Humans; Hydroxychloroquine; Male; Radiography; Time Factors

1982
Validity of single variables and indices to measure disease activity in rheumatoid arthritis.
    The Journal of rheumatology, 1993, Volume: 20, Issue:3

    Topics: Arthritis, Rheumatoid; Azathioprine; Blood Sedimentation; C-Reactive Protein; Disabled Persons; Hemoglobins; Humans; Hydroxychloroquine; Joints; Methotrexate; Pain; Reproducibility of Results; Severity of Illness Index; Sulfasalazine

1993
The relative toxicity of disease-modifying antirheumatic drugs.
    Arthritis and rheumatism, 1993, Volume: 36, Issue:3

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Azathioprine; Humans; Hydroxychloroquine; Longitudinal Studies; Methotrexate; Penicillamine; Prednisone; Prospective Studies

1993
A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group.
    Lupus, 1998, Volume: 7, Issue:2

    Topics: Adult; Antimalarials; Azathioprine; Cyclophosphamide; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Retrospective Studies; Substance Withdrawal Syndrome; Time Factors

1998
The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus.
    Scandinavian journal of immunology, 2006, Volume: 63, Issue:4

    Topics: Adult; Antibodies, Anticardiolipin; Antirheumatic Agents; Azathioprine; B-Cell Activating Factor; Case-Control Studies; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Membrane Proteins; Middle Aged; Prednisolone; Quinacrine; Severity of Illness Index; Tumor Necrosis Factor-alpha

2006
Extrapolation of Adult Efficacy Data to Pediatric Systemic Lupus Erythematosus: Evaluating Similarities in Exposure-Response.
    Journal of clinical pharmacology, 2023, Volume: 63, Issue:1

    Topics: Adult; Azathioprine; Child; Cyclophosphamide; Enzyme Inhibitors; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Rituximab; Treatment Outcome

2023

Other Studies

97 other study(ies) available for azathioprine and hydroxychloroquine

ArticleYear
Antirheumatic agents.
    The Journal of the Maine Medical Association, 1979, Volume: 70, Issue:4

    Topics: Adrenal Cortex Hormones; Antimalarials; Aspirin; Azathioprine; Chloroquine; Cyclophosphamide; Gold; Humans; Hydroxychloroquine; Immunosuppressive Agents; Indomethacin; Penicillamine; Phenylbutazone; Phenylpropionates; Rheumatic Diseases; Salicylates; Sulindac; Tolmetin

1979
Assessment of anti-inflammatory drugs in the rat using subcutaneous implants of polyurethane foam impregnated with dead tubercle bacilli.
    Annals of the rheumatic diseases, 1975, Volume: 34, Issue:4

    Topics: Animals; Anti-Inflammatory Agents; Aspirin; Azathioprine; Biological Assay; Cyclophosphamide; Female; Gold Sodium Thiomalate; Hydroxychloroquine; Inflammation; Mycobacterium tuberculosis; Penicillamine; Phenylbutazone; Polyurethanes; Prednisolone; Rats

1975
Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone.
    The Journal of rheumatology, 1992, Volume: 19, Issue:12

    Topics: Age Factors; Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Gold; Humans; Hydroxychloroquine; Long-Term Care; Methotrexate; Middle Aged; Penicillamine; Prednisone; Private Practice

1992
Pemphigus foliaceus. Use of antimalarial agents as adjuvant therapy.
    Archives of dermatology, 1992, Volume: 128, Issue:11

    Topics: Aged; Azathioprine; Chemotherapy, Adjuvant; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Pemphigus; Prednisone; Sunlight

1992
Drugs for rheumatoid arthritis.
    The Medical letter on drugs and therapeutics, 1991, Jul-12, Volume: 33, Issue:848

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Azathioprine; Costs and Cost Analysis; Drugs, Investigational; Humans; Hydroxychloroquine; Methotrexate; Monitoring, Physiologic; Organogold Compounds; Penicillamine; Sulfasalazine

1991
Drugs for rheumatoid arthritis.
    The Medical letter on drugs and therapeutics, 1989, Jun-30, Volume: 31, Issue:795

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Gold; Humans; Hydroxychloroquine; Methotrexate; Penicillamine; Salicylates; Sulfasalazine

1989
Intractable RA--treatment with combined methotrexate, azathioprine and hydroxychloroquine.
    British journal of rheumatology, 1989, Volume: 28, Issue:3

    Topics: Adult; Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Methotrexate; Middle Aged

1989
Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.
    The Nurse practitioner, 1987, Volume: 12, Issue:3

    Topics: Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Gold; Humans; Hydroxychloroquine; Methotrexate; Penicillamine; Sulfasalazine

1987
Treatment of discoid skin lesions with azathioprine.
    Archives of dermatology, 1986, Volume: 122, Issue:7

    Topics: Azathioprine; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Discoid; Quinacrine

1986
Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
    Texas medicine, 1985, Volume: 81, Issue:9

    Topics: Arthritis, Rheumatoid; Aurothioglucose; Azathioprine; Cyclophosphamide; Gold; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Methotrexate; Penicillamine

1985
Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study.
    JAMA, 1986, May-02, Volume: 255, Issue:17

    Topics: Adult; Aged; Arthritis, Rheumatoid; Azathioprine; Blood Sedimentation; Cyclophosphamide; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Hemoglobins; Humans; Hydroxychloroquine; Immunoglobulin M; Leukocyte Count; Male; Middle Aged; Radiography; Rheumatoid Factor

1986
Two first degree relatives with dilatation of the colon due to Crohn's disease.
    Guy's Hospital reports, 1973, Volume: 122, Issue:3-4

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Azathioprine; Body Weight; Colectomy; Colitis, Ulcerative; Colon; Colonic Diseases; Crohn Disease; Diagnosis, Differential; Diarrhea; Dilatation; Erythema Nodosum; Female; Humans; Hydroxychloroquine; Ileostomy; Intestinal Mucosa; Prednisolone; Rectum; Sigmoidoscopy

1973
The effects of chloroquine on canine renal allografts.
    Transplantation, 1967, Volume: 5, Issue:4

    Topics: Animals; Azathioprine; Dogs; Hydroxychloroquine; Kidney Transplantation; Transplantation, Homologous

1967
Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine.
    Journal of the American Academy of Dermatology, 1984, Volume: 10, Issue:4

    Topics: Adenocarcinoma; Adolescent; Adult; Azathioprine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prednisone; Uterine Neoplasms

1984
Actinic reticuloid. Response to combination treatment with azathioprine, hydroxychloroquine, and prednisone.
    Journal of the American Academy of Dermatology, 1984, Volume: 10, Issue:6

    Topics: Azathioprine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Male; Middle Aged; Photosensitivity Disorders; Plastics; Prednisone; Protective Devices

1984
An overview of benefit/risk of disease modifying treatment of rheumatoid arthritis as of today.
    Annals of the rheumatic diseases, 1982, Volume: 41 Suppl 1

    Topics: Arthritis, Rheumatoid; Azathioprine; Chloroquine; Cyclophosphamide; Female; Gold; Humans; Hydroxychloroquine; Levamisole; Macular Degeneration; Male; Neoplasms; Pancytopenia; Penicillamine; Risk

1982
Heroic treatment for nonmalignant disease.
    JAMA, 1982, Oct-08, Volume: 248, Issue:14

    Topics: Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Humans; Hydroxychloroquine

1982
Phosphorus 31 magnetic resonance spectroscopy for quantitative evaluation of therapeutic regimens in dermatomyositis.
    Archives of dermatology, 1995, Volume: 131, Issue:5

    Topics: Adenosine Triphosphate; Adult; Azathioprine; Dermatomyositis; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Immunosuppressive Agents; Longitudinal Studies; Magnetic Resonance Spectroscopy; Methotrexate; Muscle Contraction; Muscle, Skeletal; Phosphates; Phosphocreatine; Phosphorus Isotopes; Prednisone

1995
The total costs of drug therapy for rheumatoid arthritis. A model based on costs of drug, monitoring, and toxicity.
    Arthritis and rheumatism, 1995, Volume: 38, Issue:3

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Boston; Decision Trees; Diagnosis-Related Groups; Drug Costs; Drug Monitoring; Gold; Health Care Costs; Hospitals, University; Humans; Hydroxychloroquine; Massachusetts; Methotrexate; Models, Economic; New Hampshire; Penicillamine; Sensitivity and Specificity

1995
Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs.
    Agents and actions. Supplements, 1993, Volume: 44

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Follow-Up Studies; Humans; Hydroxychloroquine; Methotrexate; Middle Aged; Organogold Compounds; Penicillamine; Prednisone; Probability

1993
Lupus and its management.
    Journal of the South Carolina Medical Association (1975), 1993, Volume: 89, Issue:11

    Topics: Adolescent; Antibiotics, Antineoplastic; Autoantibodies; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Prednisone

1993
Personal experience in the treatment of seropositive rheumatoid arthritis with drugs used in combination.
    Seminars in arthritis and rheumatism, 1993, Volume: 23, Issue:2 Suppl 1

    Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prognosis; Severity of Illness Index

1993
Cyclosporine treatment for dermatomyositis/polymyositis.
    Cutis, 1993, Volume: 51, Issue:1

    Topics: Azathioprine; Cyclosporine; Dermatomyositis; Female; Humans; Hydroxychloroquine; Middle Aged; Polymyositis; Prednisone; Quinacrine

1993
Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies.
    British journal of rheumatology, 1996, Volume: 35, Issue:2

    Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Postpartum Period; Prednisolone; Pregnancy; Pregnancy Complications; Prospective Studies

1996
[Diagnosis and treatment of rheumatoid arthritis].
    Medicina (Kaunas, Lithuania), 2002, Volume: 38, Issue:1

    Topics: Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclosporins; Diagnosis, Differential; Exercise Therapy; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prognosis; Radiography; Rheumatoid Factor; Sulfasalazine

2002
[Psoriasis and systemic lupus erythematosus: a rare association with specific therapeutic problems].
    Annales de medecine interne, 2003, Volume: 154, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antirheumatic Agents; Azathioprine; Dermatologic Agents; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Psoriasis; Time Factors

2003
[Drug alternatives in therapy of neuropsychiatric systemic lupus erythematosus (NPSLE)].
    Medizinische Klinik (Munich, Germany : 1983), 2003, Jun-15, Volume: 98, Issue:6

    Topics: Antibodies, Antiphospholipid; Anticoagulants; Antirheumatic Agents; Azathioprine; Coumarins; Cyclophosphamide; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Immunosuppressive Agents; Longitudinal Studies; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Male; Pregnancy; Time Factors

2003
Bilateral cytomegalovirus retinitis in a patient with systemic lupus erythematosus and end-stage renal disease.
    Mayo Clinic proceedings, 2003, Volume: 78, Issue:11

    Topics: Adult; Antirheumatic Agents; Azathioprine; Cytomegalovirus Retinitis; Female; HIV Seronegativity; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Renal Dialysis

2003
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy.
    Toxicology letters, 2004, Apr-01, Volume: 149, Issue:1-3

    Topics: Adult; Aspirin; Autoimmune Diseases; Azathioprine; Cyclosporine; Dexamethasone; Female; Hemoglobins; Hepatitis Antibodies; Hepatitis B Vaccines; Humans; Hydroxychloroquine; Immune System; Immunoglobulin G; Immunoglobulins; Immunosuppressive Agents; Infant; Infant, Newborn; Leukocyte Count; Lymphocyte Count; Male; Platelet Count; Prednisone; Pregnancy; Vaccination

2004
Lupus cystitis in association with severe gastrointestinal manifestations in an adolescent.
    The Journal of rheumatology, 2005, Volume: 32, Issue:1

    Topics: Adolescent; Antirheumatic Agents; Azathioprine; Cystitis, Interstitial; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Hydroxychloroquine; Immunosuppressive Agents; Injections, Intravenous; Lupus Erythematosus, Systemic; Methylprednisolone; Pulse Therapy, Drug; Tomography, X-Ray Computed; Treatment Outcome

2005
[Symmetric polyarthritis in a patient with Churg-Strauss syndrome].
    Deutsche medizinische Wochenschrift (1946), 2005, Aug-19, Volume: 130, Issue:33

    Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis; Azathioprine; Churg-Strauss Syndrome; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Recurrence; Sulfasalazine

2005
Twelve years experience of juvenile dermatomyositis in North India.
    Rheumatology international, 2006, Volume: 26, Issue:6

    Topics: Adolescent; Age of Onset; Azathioprine; Calcinosis; Child; Child, Preschool; Deglutition Disorders; Dermatomyositis; Female; Follow-Up Studies; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins; India; Lipodystrophy; Male; Medical Records; Methotrexate; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome; Ulcer

2006
Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.
    Annals of the rheumatic diseases, 2006, Volume: 65, Issue:7

    Topics: Adult; Aged; Antibodies, Viral; Azathioprine; Case-Control Studies; Female; Hemagglutination Inhibition Tests; Humans; Hydroxychloroquine; Immunosuppressive Agents; Influenza Vaccines; Lupus Erythematosus, Systemic; Male; Middle Aged; Orthomyxoviridae; Prednisone; Statistics, Nonparametric; Vaccination

2006
Sustained remission of lupus nephritis.
    Lupus, 2006, Volume: 15, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Antirheumatic Agents; Azathioprine; Creatinine; Cyclophosphamide; Disease Progression; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Logistic Models; Lupus Nephritis; Male; Multivariate Analysis; Remission Induction; Retrospective Studies; Treatment Outcome

2006
The dynamism of cutaneous lupus erythematosus: mild discoid lupus erythematosus evolving into SLE with SCLE and treatment-resistant lupus panniculitis.
    Clinical rheumatology, 2007, Volume: 26, Issue:7

    Topics: Antimalarials; Azathioprine; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Methylprednisolone; Middle Aged; Panniculitis, Lupus Erythematosus; Pulse Therapy, Drug; Tacrolimus; Treatment Failure

2007
Severe gastrointestinal inflammation in adult dermatomyositis: characterization of a novel clinical association.
    The American journal of the medical sciences, 2006, Volume: 332, Issue:6

    Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Dermatomyositis; Fatal Outcome; Female; Gastrointestinal Diseases; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunosuppressive Agents; Inflammation; Methotrexate; Prednisolone

2006
[Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2007, Volume: 104, Issue:10

    Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Azathioprine; Child; Chloroquine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroretinography; Female; Fundus Oculi; Humans; Hydroxychloroquine; Long-Term Care; Lupus Erythematosus, Systemic; Macula Lutea; Male; Middle Aged; Ophthalmoscopy; Prednisolone; Retina; Retinal Diseases; Visual Fields

2007
Immune system development in infants born to mothers with autoimmune disease, exposed in utero to immunosuppressive agents.
    American journal of perinatology, 2007, Volume: 24, Issue:8

    Topics: Autoimmune Diseases; Azathioprine; Cyclosporine; Female; Humans; Hydroxychloroquine; Immune System; Immunoglobulin Isotypes; Immunophenotyping; Immunosuppressive Agents; Infant; Infant, Newborn; Leukocytes, Mononuclear; Lymphocyte Count; Lymphocyte Subsets; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Prospective Studies

2007
Disease-modifying antirheumatic drugs.
    The Journal of hand surgery, 2009, Volume: 34, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine

2009
Primary antiphospholipid antibody syndrome and autoimmune haemolytic anaemia--a rare combination.
    JPMA. The Journal of the Pakistan Medical Association, 2009, Volume: 59, Issue:6

    Topics: Adolescent; Adrenal Cortex Hormones; Anemia, Hemolytic, Autoimmune; Anticoagulants; Antiphospholipid Syndrome; Antirheumatic Agents; Azathioprine; Comorbidity; Female; Glucocorticoids; Humans; Hydroxychloroquine; Prednisolone; Warfarin

2009
Acute generalized exanthematous pustulosis and toxic epidermal necrolysis induced by hydroxychloroquine.
    Clinical rheumatology, 2009, Volume: 28, Issue:12

    Topics: Aged; Antirheumatic Agents; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Skin Diseases, Vesiculobullous; Stevens-Johnson Syndrome; Treatment Outcome

2009
Enhanced adhesive properties of endothelial progenitor cells (EPCs) in patients with SLE.
    Rheumatology international, 2011, Volume: 31, Issue:6

    Topics: Adult; Antirheumatic Agents; Azathioprine; Cell Adhesion; Cells, Cultured; Colony-Forming Units Assay; Drug Therapy, Combination; Endothelium, Vascular; Female; Fibronectins; Glucocorticoids; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Severity of Illness Index; Stem Cells

2011
Pulmonary amyloidosis in Sjögren's syndrome: a rare diagnosis for nodular lung lesions.
    International journal of rheumatic diseases, 2009, Volume: 12, Issue:4

    Topics: Amyloid; Amyloidosis; Antirheumatic Agents; Azathioprine; Coloring Agents; Congo Red; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Lung Diseases; Middle Aged; Prednisone; Sjogren's Syndrome; Treatment Outcome

2009
A non-BRICHOS surfactant protein c mutation disrupts epithelial cell function and intercellular signaling.
    BMC cell biology, 2010, Nov-20, Volume: 11

    Topics: Amino Acid Substitution; Animals; Azathioprine; Bronchoalveolar Lavage Fluid; Calnexin; Calreticulin; CD4-Positive T-Lymphocytes; Cell Line; Cyclophosphamide; Epithelial Cells; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Hydroxychloroquine; Lung Diseases, Interstitial; Methylprednisolone; Mice; Mutation; Phosphatidylcholines; Pulmonary Surfactant-Associated Protein C; Receptors, CCR2; Receptors, Interleukin-8A; Signal Transduction

2010
Large leg ulcers due to autoimmune diseases.
    Medical science monitor : international medical journal of experimental and clinical research, 2011, Volume: 17, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Autoimmune Diseases; Azathioprine; Ciprofloxacin; Cyclophosphamide; Cyclosporine; Female; Humans; Hydroxychloroquine; Hyperbaric Oxygenation; Infliximab; Larva; Leg Ulcer; Male; Methylprednisolone; Middle Aged; Prednisolone; Skin Transplantation; Treatment Outcome; Vancomycin; Vasculitis; Young Adult

2011
Mixed connective tissue disorder and Castleman's disease.
    The Journal of the Association of Physicians of India, 2010, Volume: 58

    Topics: Adolescent; Azathioprine; Biopsy; Castleman Disease; Female; Glomerulonephritis, Membranoproliferative; Humans; Hydroxychloroquine; Mixed Connective Tissue Disease; Prednisolone; Tomography, X-Ray Computed; Treatment Outcome

2010
A case of primary Sjögren's syndrome presenting primarily with central nervous system vasculitic involvement.
    Rheumatology international, 2012, Volume: 32, Issue:3

    Topics: Adult; Angiography, Digital Subtraction; Azathioprine; Brain; Central Nervous System Diseases; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Magnetic Resonance Imaging; Prednisolone; Sjogren's Syndrome; Vasculitis

2012
Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases.
    Scandinavian journal of gastroenterology, 2011, Volume: 46, Issue:6

    Topics: Adult; Antibodies, Antinuclear; Azathioprine; Biopsy; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis, Autoimmune; Humans; Hydroxychloroquine; Immunoblotting; Immunoglobulin G; Liver Cirrhosis, Biliary; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Prevalence; Retrospective Studies; Syndrome; Treatment Outcome; Ursodeoxycholic Acid

2011
A tale of two rashes.
    The American journal of medicine, 2011, Volume: 124, Issue:5

    Topics: Aged; Antihypertensive Agents; Azathioprine; Complement C4; Cryoglobulinemia; Diagnosis, Differential; Drug Eruptions; Exanthema; Female; Humans; Hydralazine; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Plasmapheresis; Prednisone; Venous Thrombosis

2011
Primary sjögren syndrome manifested as localized cutaneous nodular amyloidosis.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2011, Volume: 17, Issue:7

    Topics: Aged; Amyloidosis; Antirheumatic Agents; Azathioprine; Female; Humans; Hydroxychloroquine; Immunohistochemistry; Prednisone; Sjogren's Syndrome; Skin Diseases

2011
Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients.
    Rheumatology (Oxford, England), 2012, Volume: 51, Issue:3

    Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Colchicine; Drug Therapy, Combination; Eosinophilia; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Scleroderma, Localized; Synovitis; Treatment Outcome

2012
Idiopathic mediastinal fibrosis presenting with antiphospholipid antibody syndrome and manifestations suggestive of connective tissue disease.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2012, Volume: 18, Issue:3

    Topics: Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Antirheumatic Agents; Azathioprine; Connective Tissue Diseases; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Mediastinitis; Middle Aged; Prednisone; Sclerosis; Thoracoscopy; Tomography, X-Ray Computed

2012
The surfactant protein C mutation A116D alters cellular processing, stress tolerance, surfactant lipid composition, and immune cell activation.
    BMC pulmonary medicine, 2012, Mar-29, Volume: 12

    Topics: Animals; Azathioprine; Cell Line; Cyclophosphamide; Epithelial Cells; Gene Expression; Humans; Hydroxychloroquine; Lung Diseases, Interstitial; Methylprednisolone; Mice; Molecular Chaperones; Mutation; Phospholipids; Pulmonary Alveoli; Pulmonary Surfactant-Associated Protein C; Pulmonary Surfactants

2012
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.
    Annals of the rheumatic diseases, 2012, Volume: 71, Issue:11

    Topics: Adult; Azathioprine; Biopsy; Child; Cyclophosphamide; Disease Management; Dose-Response Relationship, Drug; Drug Substitution; Drug Therapy, Combination; Evidence-Based Medicine; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Mycophenolic Acid; Pregnancy

2012
Devic syndrome: can antiphospholipid antibodies be a factor?
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2012, Volume: 18, Issue:8

    Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antirheumatic Agents; Aspirin; Atorvastatin; Azathioprine; Complement C4; Cyclophosphamide; Female; Glucocorticoids; Heparin; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Plasmapheresis; Prednisolone; Pulse Therapy, Drug; Pyrroles; Warfarin

2012
Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis.
    Journal of clinical apheresis, 2013, Volume: 28, Issue:6

    Topics: Aged; Autoantibodies; Azathioprine; Combined Modality Therapy; Creatine Kinase; Cyclophosphamide; Emergencies; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lung Diseases, Interstitial; Methylprednisolone; Myositis; Plasma; Plasmapheresis; Pulmonary Diffusing Capacity; Remission Induction

2013
Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history.
    Seminars in arthritis and rheumatism, 2014, Volume: 43, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Comorbidity; Female; Glatiramer Acetate; Greece; Humans; Hydroxychloroquine; Immunologic Factors; Immunosuppressive Agents; Interferon-beta; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Multiple Sclerosis; Natalizumab; Peptides; Prevalence; Rituximab

2014
The influence of therapy on CD4+CD25(high)FOXP3+ regulatory T cells in systemic lupus erythematosus patients: a prospective study.
    Scandinavian journal of rheumatology, 2015, Volume: 44, Issue:1

    Topics: Adult; Azathioprine; CD4 Antigens; Cyclophosphamide; Female; Flow Cytometry; Forkhead Transcription Factors; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interleukin-2 Receptor alpha Subunit; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Middle Aged; Prospective Studies; Pulse Therapy, Drug; Remission Induction; T-Lymphocytes, Regulatory

2015
Psoriatic arthritis treatment and the risk of herpes zoster.
    Annals of the rheumatic diseases, 2016, Volume: 75, Issue:1

    Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Drug Combinations; Drug Therapy, Combination; Etanercept; Female; Glucosamine; Herpes Zoster; Humans; Hydroxychloroquine; Incidence; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Tumor Necrosis Factor-alpha

2016
Antiphospholipid antibodies-associated diffuse alveolar hemorrhage.
    Seminars in arthritis and rheumatism, 2015, Volume: 44, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Azathioprine; Biopsy; Cohort Studies; Cyclophosphamide; Female; Hemorrhage; Humans; Hydroxychloroquine; Lung; Lung Diseases; Male; Methotrexate; Middle Aged; Plasma Exchange; Retrospective Studies; Rituximab

2015
Chronic alveolar haemorrhage in a paediatric patient: a diagnostic and treatment challenge.
    BMJ case reports, 2015, Apr-21, Volume: 2015

    Topics: Adolescent; Adrenal Cortex Hormones; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Biopsy; Cyclophosphamide; Female; Hemoptysis; Hemorrhage; Hemosiderosis; Hemosiderosis, Pulmonary; Humans; Hydroxychloroquine; Lung Diseases; Peroxidase; Rituximab; Vasculitis

2015
Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.
    Clinical rheumatology, 2015, Volume: 34, Issue:6

    Topics: Adalimumab; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Hepatitis C, Chronic; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha

2015
Specific systemic lupus erythematosus disease manifestations in the six months prior to conception are associated with similar disease manifestations during pregnancy.
    Lupus, 2015, Volume: 24, Issue:12

    Topics: Adult; Antirheumatic Agents; Azathioprine; Female; Humans; Hydroxychloroquine; Logistic Models; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Lupus Nephritis; Multivariate Analysis; Pregnancy; Pregnancy Complications; Retrospective Studies; Young Adult

2015
The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies.
    American journal of obstetrics and gynecology, 2016, Volume: 214, Issue:2

    Topics: Adolescent; Adult; Antibodies, Antinuclear; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Antirheumatic Agents; Azathioprine; Case-Control Studies; Cohort Studies; Comorbidity; Delivery, Obstetric; Female; Glucocorticoids; Humans; Hydroxychloroquine; Logistic Models; Lupus Erythematosus, Systemic; Multivariate Analysis; Odds Ratio; Prednisolone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Treatment Outcome; Young Adult

2016
Unilateral unique Lupus tumidus: pathogenetic mystery and diagnostic problem.
    Wiener medizinische Wochenschrift (1946), 2016, Volume: 166, Issue:7-8

    Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Biopsy; Chloroquine; Combined Modality Therapy; Dapsone; Diagnosis, Differential; Humans; Hydroxychloroquine; Lasers, Dye; Lupus Erythematosus, Discoid; Male; Ointments; Quinacrine; Skin; Sunscreening Agents; Tacrolimus

2016
Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis.
    Epidemiology (Cambridge, Mass.), 2016, Volume: 27, Issue:3

    Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Certolizumab Pegol; Cohort Studies; Cyclophosphamide; Etanercept; Female; Humans; Hydroxychloroquine; Hypertension; Incidence; Infliximab; Male; Methotrexate; Middle Aged; Minocycline; Penicillamine; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sulfasalazine; Tumor Necrosis Factor-alpha

2016
Drugs used in incident systemic lupus erythematosus - results from the Finnish nationwide register 2000-2007.
    Lupus, 2016, Volume: 25, Issue:6

    Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Chronic Disease; Female; Finland; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Registries

2016
Breastfeeding in mothers with systemic lupus erythematosus.
    Lupus, 2016, Volume: 25, Issue:9

    Topics: Adult; Azathioprine; Breast Feeding; Databases, Factual; Decision Making; Female; Humans; Hydroxychloroquine; Infant; Lupus Erythematosus, Systemic; Methotrexate; Milk, Human; Mothers; Prednisolone; Pregnancy; Prospective Studies; Socioeconomic Factors; Young Adult

2016
Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
    Journal of the American Academy of Dermatology, 2016, Volume: 75, Issue:1

    Topics: Administration, Intravenous; Administration, Oral; Adrenal Cortex Hormones; Adult; Azathioprine; Case-Control Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Herpes Zoster; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Retrospective Studies; Risk Factors; Taiwan; Young Adult

2016
Juvenile systemic lupus erythematosus in Nigeria.
    Lupus, 2017, Volume: 26, Issue:3

    Topics: Adolescent; Antibodies, Antinuclear; Antirheumatic Agents; Azathioprine; Child; Female; Hospitals, Teaching; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Nigeria; Retrospective Studies; Rituximab; Severity of Illness Index; Treatment Outcome

2017
New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab.
    Seminars in arthritis and rheumatism, 2017, Volume: 46, Issue:6

    Topics: Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Disease Progression; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Prednisone

2017
Psoriasis in systemic lupus erythematosus: a single-center experience.
    Clinical rheumatology, 2017, Volume: 36, Issue:4

    Topics: Adolescent; Adult; Antirheumatic Agents; Azathioprine; Cohort Studies; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Methotrexate; Ontario; Psoriasis; Young Adult

2017
Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.
    Arthritis & rheumatology (Hoboken, N.J.), 2018, Volume: 70, Issue:5

    Topics: Antirheumatic Agents; Azathioprine; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Dermatomyositis; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Models, Statistical; Retrospective Studies; Severity of Illness Index; Treatment Outcome; United Kingdom

2018
Commonly used medication for Lupus.
    Lupus, 2018, Volume: 27, Issue:1_suppl

    Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Disease Management; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methotrexate; Mycophenolic Acid; Rituximab

2018
Early Initiation of Steroid-sparing Drugs in Idiopathic Pulmonary Hemosiderosis.
    Indian pediatrics, 2019, 01-15, Volume: 56, Issue:1

    Topics: Azathioprine; Child; Hemosiderosis; Hemosiderosis, Pulmonary; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lung Diseases; Time-to-Treatment

2019
Successful conception in a 34-year-old lupus patient following spontaneous pregnancy after autotransplantation of cryopreserved ovarian tissue.
    Lupus, 2019, Volume: 28, Issue:5

    Topics: Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Cryopreservation; Cyclophosphamide; Female; Fertility Preservation; Gonadotropin-Releasing Hormone; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Ovary; Pregnancy; Pregnancy Outcome; Pregnancy, Twin; Premature Birth; Transplantation, Autologous

2019
Acute pulmonary embolism in a child with ANCA-negative Idiopathic Pulmonary Capillaritis.
    Saudi medical journal, 2019, Volume: 40, Issue:6

    Topics: Acute Disease; Antibodies, Antineutrophil Cytoplasmic; Capillaries; Chest Pain; Child; Female; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Hydroxychloroquine; Hypoxia; Lung; Lung Diseases; Mercaptopurine; Prednisolone; Pulmonary Alveoli; Pulmonary Embolism; Treatment Outcome; Vasculitis

2019
Perinatal use and discontinuation of disease-modifying anti-rheumatic drugs and biologics in women with rheumatoid arthritis: a cohort study.
    Rheumatology (Oxford, England), 2020, 07-01, Volume: 59, Issue:7

    Topics: Abatacept; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Biological Products; British Columbia; Chloroquine; Cohort Studies; Cyclophosphamide; Cyclosporine; Deprescriptions; Female; Glucocorticoids; Gold Compounds; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Leflunomide; Logistic Models; Maternal Age; Methotrexate; Mycophenolic Acid; Odds Ratio; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Rheumatology; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors

2020
Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.
    Rheumatology (Oxford, England), 2020, 07-01, Volume: 59, Issue:7

    Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cyclosporine; Deprescriptions; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Protective Factors; Recurrence; Remission Induction; Risk Factors; Symptom Flare Up; Time Factors

2020
Inclusion-body myositis and primary Sjögren syndrome: mechanisms for shared etiologies.
    Muscle & nerve, 2020, Volume: 61, Issue:5

    Topics: 5'-Nucleotidase; Adult; Autoantibodies; Azathioprine; CD8-Positive T-Lymphocytes; Female; Haplotypes; HLA Antigens; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Leukemia, Large Granular Lymphocytic; Magnetic Resonance Imaging; Methotrexate; Muscle, Skeletal; Myositis, Inclusion Body; Prednisolone; Rituximab; Sjogren's Syndrome

2020
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
    Annals of the rheumatic diseases, 2020, Volume: 79, Issue:6

    Topics: Antirheumatic Agents; Azathioprine; Calcineurin Inhibitors; Drug Therapy, Combination; Europe; Glomerular Filtration Rate; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Mycophenolic Acid; Proteinuria; Societies, Medical

2020
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
    Annals of the rheumatic diseases, 2020, Volume: 79, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Cyclosporine; Diarrhea; Dysgeusia; Dyspnea; Fatigue; Female; Fever; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Incidence; Intensive Care Units; Italy; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Respiratory Distress Syndrome; SARS-CoV-2; Telemedicine

2020
Clinical features and outcomes from the Singapore Sjögren's syndrome study.
    Lupus, 2021, Volume: 30, Issue:2

    Topics: Adult; Arthralgia; Azathioprine; Female; Humans; Hydroxychloroquine; Keratoconjunctivitis Sicca; Male; Methotrexate; Methylprednisolone; Middle Aged; Peripheral Nervous System Diseases; Retrospective Studies; Singapore; Sjogren's Syndrome; Xerostomia

2021
Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation.
    The Journal of pediatrics, 2021, Volume: 231

    Topics: Adolescent; Azathioprine; Child; Child, Preschool; Chronic Disease; Female; Humans; Hydroxychloroquine; Immunomodulation; Infant; Male; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Rituximab; Splenectomy

2021
Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom.
    Lupus, 2021, Volume: 30, Issue:5

    Topics: Adult; Antirheumatic Agents; Azathioprine; Cardiovascular Diseases; Cause of Death; Cohort Studies; Enzyme Inhibitors; Female; Humans; Hydroxychloroquine; Immunocompromised Host; Infections; Lupus Erythematosus, Systemic; Male; Middle Aged; Morbidity; Mortality, Premature; Mycophenolic Acid; Neoplasms; Retrospective Studies; Risk Factors; Rituximab; Steroids; Survival Rate; Time Factors; United Kingdom

2021
Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service.
    Clinical and experimental dermatology, 2021, Volume: 46, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Clinical Protocols; Dermatologic Agents; Female; Humans; Hydroxychloroquine; Interleukin-12; Interleukin-23; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Phenotype; Prospective Studies; Quinacrine; Referral and Consultation; Remission Induction; Sarcoidosis; Skin Diseases; Tertiary Care Centers; Tumor Necrosis Factor Inhibitors; Young Adult

2021
Infection hospitalisation in systemic lupus in Sweden.
    Lupus science & medicine, 2021, Volume: 8, Issue:1

    Topics: Antirheumatic Agents; Azathioprine; Hospitalization; Humans; Hydroxychloroquine; Sweden

2021
Annular erythematous plaques as manifestation of vasculitis in pediatric Sjögren's syndrome.
    Rheumatology (Oxford, England), 2022, 02-02, Volume: 61, Issue:2

    Topics: Antirheumatic Agents; Azathioprine; Child; Erythema; Face; Female; Fingers; Humans; Hydroxychloroquine; Sjogren's Syndrome; Vasculitis, Leukocytoclastic, Cutaneous

2022
Remission or low disease activity at pregnancy onset are linked to improved foetal outcomes in women with systemic lupus erythematosus: results from a prospective observational study.
    Clinical and experimental rheumatology, 2022, Volume: 40, Issue:9

    Topics: Antibodies, Antiphospholipid; Azathioprine; Female; Glucocorticoids; Humans; Hydroxychloroquine; Infant, Newborn; Lupus Erythematosus, Systemic; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies

2022
Alopecia Universalis Associated with Hyperthyroidism Treated with Azathioprine and Hydroxychloroquine: A Case Report.
    JNMA; journal of the Nepal Medical Association, 2021, Sep-11, Volume: 59, Issue:241

    Topics: Alopecia; Alopecia Areata; Azathioprine; Female; Humans; Hydroxychloroquine; Hyperthyroidism

2021
In-utero exposure to immunosuppressive medications resulting in abnormal newborn screening for severe combined immunodeficiency: a case series on natural history and management.
    Immunologic research, 2022, Volume: 70, Issue:5

    Topics: Actins; Azathioprine; Female; Fingolimod Hydrochloride; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Infliximab; Lymphopenia; Mitogens; Neonatal Screening; Receptors, Antigen, T-Cell; Severe Combined Immunodeficiency; Vaccines

2022
Impaired adrenal cortex reserve in patients with rheumatic and musculoskeletal diseases who relapse upon tapering of low glucocorticoid dose.
    Clinical and experimental rheumatology, 2022, Volume: 40, Issue:9

    Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Insufficiency; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chronic Disease; Cosyntropin; Glucocorticoids; Humans; Hydrocortisone; Hydroxychloroquine; Leflunomide; Methotrexate; Prednisolone; Recurrence; Tumor Necrosis Factor Inhibitors

2022
Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine.
    Rheumatology (Oxford, England), 2023, 03-01, Volume: 62, Issue:3

    Topics: Adolescent; Antirheumatic Agents; Azathioprine; Child; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Pregnancy; Pregnancy Complications; Premature Birth; Retrospective Studies

2023
Perspective of sarcoidosis in terms of rheumatology: a single-center rheumatology clinic experience.
    Rheumatology international, 2022, Volume: 42, Issue:12

    Topics: Adrenal Cortex Hormones; Ambulatory Care Facilities; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Azathioprine; Cross-Sectional Studies; Female; Humans; Hydroxychloroquine; Infliximab; Male; Methotrexate; Retrospective Studies; Rheumatic Diseases; Rheumatology; Sarcoidosis

2022
Management of Hepatic Sarcoidosis.
    Journal of gastrointestinal and liver diseases : JGLD, 2022, 09-15, Volume: 31, Issue:3

    Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Digestive System Diseases; Humans; Hydroxychloroquine; Mycophenolic Acid; Sarcoidosis

2022
Impact of the COVID-19 pandemic on prescription refills for immune-mediated inflammatory disorders: a time series analysis (January 2019 to January 2021) using the English Prescribing Dataset.
    BMJ open, 2022, 12-23, Volume: 12, Issue:12

    Topics: Azathioprine; Communicable Disease Control; COVID-19; Drug Prescriptions; Humans; Hydroxychloroquine; Leflunomide; Methotrexate; Pandemics; Sulfasalazine; Time Factors

2022
Association of patient copayment and medication adherence in systemic lupus erythematosus.
    Lupus science & medicine, 2023, Volume: 10, Issue:2

    Topics: Adult; Aged; Azathioprine; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Medication Adherence; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies

2023